Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience

Diego Cruz Vidal1, Simon Lee2, Stacy P Ardoin3

  • 1From the Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.

Insights

Multisystem inflammatory syndrome in children (MIS-C) can cause heart problems. Lower albumin and specific blood markers like ferritin and IL-6 are linked to cardiac dysfunction in pediatric MIS-C patients.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition following viral infections.
  • Cardiac involvement is a significant concern in pediatric MIS-C, impacting disease severity.

Purpose of the Study:

  • To identify clinical and laboratory predictors of cardiac involvement in MIS-C.
  • To understand factors associated with severe presentations of MIS-C.

Main Methods:

  • Prospective analysis of 146 pediatric patients diagnosed with MIS-C.
  • Evaluation of clinical data and laboratory markers, including cardiac function and coronary artery status.

Main Results:

  • 45.2% of patients exhibited cardiac dysfunction; 17.8% had coronary artery abnormalities.
  • Lower serum albumin, lymphocyte, and platelet counts were associated with cardiac dysfunction.
  • Elevated ferritin, fibrinogen, d-dimer, and interleukin-6 levels correlated with cardiac dysfunction.

Conclusions:

  • Specific laboratory markers can predict cardiac involvement in children with MIS-C.
  • Early identification of at-risk patients may guide management and potentially prevent severe outcomes.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...